Arrowhead Research | ARWR - 普通株資本





普通株資本 変化する 日付
Agios Pharmaceuticals USD 59.34M 892K 2026-03
Alnylam Pharmaceuticals USD 133.44M 1.07M 2026-03
Anika Therapeutics USD 13.89M 532K 2025-12
Arrowhead Research USD 135.7M 2.44M 2025-09
Heron Therapeutics USD 188.31M 4.99M 2025-12
Incyte USD 199.95M 1.49M 2026-03
Ionis Pharmaceuticals USD 165.9M 3.93M 2026-03
Ligand Pharmaceuticals USD 19.66M 19.64M 2025-09
Merck USD 2.47B 12.72M 2025-12
Moderna USD 391M 2M 2025-09
Nektar Therapeutics USD 20.38M 20.36M 2025-12
Novartis USD 1.91B 60K 2026-03
Sarepta Therapeutics USD 104.96M 196K 2025-12
TG Therapeutics USD 155.21M 2.81M 2025-09
Ultragenyx Pharmaceutical USD 96.6M 158K 2025-12
Vertex Pharmaceuticals USD 254.2M 200K 2026-03
Xencor USD 71.87M 529K 2025-12